Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases

RMD Open. 2022 Mar;8(1):e002279. doi: 10.1136/rmdopen-2022-002279.

Authors

Affiliations

¹ Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece geofragoul@yahoo.gr.
² Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.

No abstract available

Keywords: COVID-19; autoimmune diseases; vaccination.

Publication types

Letter

MeSH terms

Autoimmune Diseases*
COVID-19* / epidemiology
COVID-19* / prevention & control
Humans
Rheumatic Diseases* / complications
SARS-CoV-2
Vaccination